← Leaderboards
Jennifer A. Wargo
Massachusetts General Hospital
$6,986,829
Attributed
$11,030,198
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,030,198 · 9
By mechanism
R01$4,605,274 · 3
T32$4,440,436 · 1
P50$826,188 · 3
K08$712,800 · 1
R21$445,500 · 1
Top collaborators
- Funda Meric-Bernstam6 shared
- Ashley M Holder4 shared
- Carrie Daniel-Macdougall2 shared
- Sherise Desiree Ferguson2 shared
- Amanda W. Lund2 shared
- Jennifer Leigh Mcquade2 shared
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMelanomaImmunotherapyImmuneMalignant NeoplasmsTumorMetastatic MelanomaInsightImmune ResponseBaseTreatment ResponseGut MicrobiomeNovel Therapeutic InterventionSamplingMolecularPathway InteractionsFecal TransplantationGut MicrobiotaIncidenceMicrobiomeCytokineAnti-Tumor Immune ResponseMouse ModelLead
Grant awards (28)
Training of Academic Surgical Oncologists$794,823
T32 · FY2025 · CA · contact PI
Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma$676,478
R01 · FY2025 · CA
Targeting the gut microbiome to inhibit melanoma lymph node metastases$515,112
R01 · FY2025 · CA · contact PI
Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma$678,399
R01 · FY2024 · CA
Training of Academic Surgical Oncologists$562,040
T32 · FY2024 · CA · contact PI
Targeting the gut microbiome to inhibit melanoma lymph node metastases$530,612
R01 · FY2024 · CA · contact PI
Elucidating the Role of the Gut and Tumor Microbiome in Malignant Glioma$202,500
R21 · FY2024 · NS
Training of Academic Surgical Oncologists$625,531
T32 · FY2023 · CA · contact PI
Elucidating the Role of the Gut and Tumor Microbiome in Malignant Glioma$243,000
R21 · FY2023 · NS
Career Enhancement Program$110,676
P50 · FY2023 · CA · contact PI
Training of Academic Surgical Oncologists$500,388
T32 · FY2022 · CA · contact PI
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome$430,292
R01 · FY2022 · CA · contact PI
Career Enhancement Program$95,769
P50 · FY2022 · CA · contact PI
Training of Academic Surgical Oncologists$604,022
T32 · FY2021 · CA
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome$448,226
R01 · FY2021 · CA · contact PI
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)$290,680
P50 · FY2021 · CA · contact PI
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome$456,293
R01 · FY2020 · CA · contact PI
Training of Academic Surgical Oncologists$386,192
T32 · FY2020 · CA
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)$329,063
P50 · FY2020 · CA · contact PI
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome$439,919
R01 · FY2019 · CA · contact PI
Training of Academic Surgical Oncologists$417,517
T32 · FY2019 · CA
Training of Academic Surgical Oncologists$549,923
T32 · FY2018 · CA
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome$429,943
R01 · FY2018 · CA · contact PI
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma$142,560
K08 · FY2016 · CA · contact PI
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma$142,560
K08 · FY2015 · CA · contact PI
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma$142,560
K08 · FY2014 · CA · contact PI
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma$142,560
K08 · FY2013 · CA · contact PI
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma$142,560
K08 · FY2012 · CA · contact PI